Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome

Editorial

Richard L Siegler. JAMA. 2003.

. 2003 Sep 10;290(10):1379-81.

doi: 10.1001/jama.290.10.1379.

No abstract available

Comment in

Farming and slaughterhouse practices to reduce meat-borne disease.
Walker ME. Walker ME. JAMA. 2003 Dec 24;290(24):3193-4; author reply 3194. doi: 10.1001/jama.290.24.3193-e. JAMA. 2003. PMID: 14693868 No abstract available.

Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial.
Trachtman H, Cnaan A, Christen E, Gibbs K, Zhao S, Acheson DW, Weiss R, Kaskel FJ, Spitzer A, Hirschman GH; Investigators of the HUS-SYNSORB Pk Multicenter Clinical Trial. Trachtman H, et al. JAMA. 2003 Sep 10;290(10):1337-44. doi: 10.1001/jama.290.10.1337. JAMA. 2003. PMID: 12966125 Clinical Trial.
Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression.
Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D, Rosas-Arellano MP, Salvadori M, Haynes RB, Clark WF. Garg AX, et al. JAMA. 2003 Sep 10;290(10):1360-70. doi: 10.1001/jama.290.10.1360. JAMA. 2003. PMID: 12966129